About AggreDYNE
AggreDYNE is a company based in Houston (United States) founded in 2011. AggreDYNE has raised $3 million across 1 funding round. AggreDYNE offers products and services including AggreGuide A-100. AggreDYNE operates in a competitive market with competitors including Accumetrics, COC Pharmaceuticals Industry, Zabit Pharmaceutical, ThrombusCheck and DCM Pharmaceutical Industry, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Agoradyne, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3 M (USD)
in 1 rounds
-
Latest Funding Round
$3 M (USD), Series A
Apr 23, 2012
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AggreDYNE
AggreDYNE offers a comprehensive portfolio of products and services, including AggreGuide A-100.
System for assessing platelet function using light scattering technology.
Funding Insights of AggreDYNE
AggreDYNE has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in April 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by AggreDYNE
Investment portfolio details for AggreDYNE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AggreDYNE
Detailed financials for AggreDYNE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aggredyne Comparisons
Peer comparison for AggreDYNE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AggreDYNE
AggreDYNE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accumetrics, COC Pharmaceuticals Industry, Zabit Pharmaceutical, ThrombusCheck and DCM Pharmaceutical Industry, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platelet function assays and coagulation systems are developed and marketed.
|
|
| Locked | Locked | Locked |
Develops diagnostic devices for platelet function analysis.
|
|
| Locked | Locked | Locked |
Develops innovative devices for platelet functioning tests.
|
|
| Locked | Locked | Locked |
Offers a device that mimics plaqued arteries for personalized anti-platelet therapy.
|
|
| Locked | Locked | Locked |
Creates innovative diagnostic devices for measuring platelet dysfunction in healthcare.
|
Detailed competitors of AggreDYNE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aggredyne
Complete news archive for AggreDYNE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AggreDYNE
AggreDYNE was founded in 2011 and raised its 1st funding round 1 year after it was founded.
AggreDYNE is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
AggreDYNE is a funded company, having raised a total of $3M across 1 funding round to date.
AggreDYNE was founded in 2011 and is headquartered in Houston, United States. Operations center on platelet function monitoring in the medical diagnostics sector. The patented Aggreguide A-100 device is employed to assess blood platelet stickiness and evaluate responses to anti-platelet therapies, such as aspirin and ADP inhibitors. Distribution occurs through 16 partners spanning 38 countries.
AggreDYNE's top competitors include Accumetrics, COC Pharmaceuticals Industry and Zabit Pharmaceutical.
AggreDYNE offers AggreGuide A-100.